Rose Merc Ltd grants 20,000 stock options under RML Employee Stock Option Plan II, 2023
Rose Merc Ltd announced that its Compensation Committee granted a total of 20,000 stock options to three eligible employees as part of the "RML Employee Stock Option Plan II 2023" (RML ESOP II 2023). The decision was made at a meeting held on June 23, 2026.Each stock option granted under the plan entitles the employee to apply for one equity share of the Company, with each share having a face value of Rs. 10/-.
The details regarding the options granted are summarized below:
| Feature | Details |
|---|---|
| Total Stock Options Granted | 20,000 |
| Number of Employees Granted To | 3 |
| Share Face Value | Rs. 10/- per equity share |
| Exercise Price per Option | Rs. 70/- |
| Vesting Period | Completion of 1 year from the date of grant |
| Total Shares Covered by Options | 20,000 Equity Shares |
The RML ESOP II 2023 was designed to be administered by the Company's Compensation Committee and is specifically granted to select employees. The terms of the grant account for various circumstances such as resignation, termination, retirement, or permanent incapacity.
Following vesting, which occurs after one year from the date of grant, the options may be exercised either wholly or partially within an exercise period of four years, or as otherwise determined by the Compensation Committee.
The plan ensures that in the event of any corporate action, such as a rights issue, bonus issue, split, consolidation, merger, amalgamation, or sale of division or undertaking, requisite adjustments will be made to the number of options granted in a fair and reasonable manner. The equity shares allotted upon the exercise of these stock options will not be subject to lock-in and will rank pari passu with all other equity shares of the Company from the date of allotment.
Stock Price Movement
Rose Merc Ltd settled at ₹65.86 today, dipping slightly by 0.15% in post-market trading. The shares moved throughout the day between an intraday low of ₹62.06 and a high of ₹66.99.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.